지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2018.1
- 수록면
- 615 - 622 (8page)
이용수
초록· 키워드
오류제보하기
Despite the well-proven, safe and effective therapies for hepatitis B infection, delivery of treatment remains a significant challenge in resource-poor settings. Geopolitical and economic restrictions present additional difficulties in providing care in North Korea. However, treatment of patients with chronic hepatitis B remains a top priority for both the North Korean Ministry of Public Health and international agencies working in North Korean hepatitis healthcare facilities. Working in partnership, a path was created to institute this much-needed program. A consortium of United States and Australian humanitarian non-governmental organizations along with generous individual and corporate donors working in concert with local and national health authorities have succeeded in establishing the first hepatitis B treatment program in North Korea. The essential elements of this program include renovation of existing hepatitis hospitals, access to antiviral medications, establishment of laboratory facilities, creation of medical documentation and record-keeping, training of local health care professionals, and quarterly visits by international volunteer physicians and laboratory experts. Management and treatment decisions are made bilaterally. To date, nearly 1,500 patients have been evaluated, and over 800 have been started on long-term antiviral therapy. It is envisioned that this program will eventually be managed and funded by the Democratic People’s Republic of Korea Ministry of Public Health. This program’s success demonstrates a potential model for delivery of antiviral therapy for patients suffering from hepatitis B in other developing countries.
목차
등록된 정보가 없습니다.
참고문헌 (2)
참고문헌 신청
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Current and future strategies for the treatment of chronic hepatitis C
Clinical and Molecular Hepatology
2021 .01
-
Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy
Gut and Liver
2017 .01
-
Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B
Gut and Liver
2016 .01
-
Hepatitis C Virus and Antiviral Drug Resistance
Gut and Liver
2016 .01
-
Real-world Effectiveness and Safety of Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C Genotype 2 Infection: Korean Multicenter Study
Journal of Korean Medical Science
2021 .01
-
Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
Gut and Liver
2021 .01
-
Estimated impact of the national hepatitis B immunization program on acute viral hepatitis B among adolescents in Republic of Korea
Osong Public Health and Research Persptectives
2023 .04
-
Another oral antiviral treatment, but still far away from hepatitis B virus cure
Clinical and Molecular Hepatology
2021 .01
-
Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
Clinical and Molecular Hepatology
2023 .01
-
De novo hepatitis B virus infection after liver transplantation in hepatitis B core-positive recipients using hepatitis B core-negative grafts
한국간담췌외과학회 학술대회지
2015 .09
-
2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C
Clinical and Molecular Hepatology
2018 .01
-
Acute hepatitis A, B and C but not D is still prevalent in Mongolia: a time trend analysis
Clinical and Molecular Hepatology
2017 .06
-
Is the Prevalence of Chronic Hepatitis B Really Increasing in Korea?
Journal of Korean Medical Science
2024 .01
-
Evaluation of the histological scoring systems of autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis
Clinical and Molecular Hepatology
2024 .04
-
Drug-drug interactions with direct-acting antivirals ? less is more
Clinical and Molecular Hepatology
2021 .01
-
Should physicians go out of the way to differentiate between acute hepatitis B and acute exacerbation of chronic hepatitis B?
Clinical and Molecular Hepatology
2020 .01
-
What is the Long-term Benefit of Direct-acting Antiviral Therapy in Chronic Hepatitis C?
Journal of Korean Medical Science
2019 .01
-
Immunotherapy for Chronic Hepatitis B Virus Infection
Gut and Liver
2018 .01
-
A challenge in distinguishing between acute hepatitis B and acute exacerbation of chronic hepatitis B
Clinical and Molecular Hepatology
2020 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0